Krishna Institute of Medical Sciences
add_icon

Krishna Institute of Medical Sciences

723.00
-8.05
(-1.10%)
Market Cap
₹30,366.47 Cr
PE Ratio
155.80
Volume
6,74,253
Day High - Low
₹737.50 - ₹717.35
52W High-Low
₹858.00 - ₹575.80
ann
Q1 Quarterly Results are out. Check out the updated financials1 day ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
30,366.47 Cr
EPS
6.03
PE Ratio
155.80
PB Ratio
7.81
Book Value
93.61
EBITDA
828.20
Dividend Yield
0.00 %
Return on Equity
9.46
Debt to Equity
1.55
Analyst Rating and Forecast
- By Refinitiv from14 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+92.86 %
+92.86 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+7.14 %
+7.14 %
Forecast For
Actual
Performance
Market Today
723.00marker-dot
Today's Low
717.35-1.10%
Today's High
737.50-1.10%
Historical Performance
723.00marker-dot
52 Week's Low
575.800.86%
52 Week's High
858.000.86%
Open731.20
High737.50
Low717.35
Prev. Close731.05
Volume6,74,253
Avg Price722.40
Lower Circuit578.40
Upper Circuit867.60
1-Year High858.00
1-Year Low575.80
3-Year High858.00
3-Year Low350.00
5-Year High858.00
5-Year Low200.00

Company News

View All News
Caret
positive
Krishna Institute of Medical Sciences reported a 40% YoY revenue jump to ₹1,344 crore in Q2FY27. Net profit rose 3.6% YoY to ₹75 crore. Board approved subsidiary merger and director reappointments.
positive
Krishna Institute of Medical Sciences' subsidiary expands KIMS Saveera Hospital from 250 to 500 beds, adding oncology and maternal care facilities.
positive
Krishna Institute of Medical Sciences acquires 51% equity in Sarvottam Health Care for ₹79.50 crore. Target reported FY26 turnover of ₹84.83 crore and PAT of ₹7.06 crore.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
723.00
#8 30,366.47
#9 155.80
#7 3,930.80
#2 28.16
#9 242
#6 3.61
52.67
8,446.00
#1 1,21,440.52
51.40
#1 25,420.10
15.58
#1 2,003
33.50
56.94
934.00
90,907.18
65.60
8,536.10
18.82
1,442
-15.63
61.17
713.15
62,163.32
173.10
4,768.80
11.25
427
-68.70
56.61
766.90
57,897.74
57.80
9,178.50
16.93
1,064
-2.52
46.62
1,903.00
38,889.86
#1 45.60
7,996.30
#1 43.43
811
16.48
65.00
1,387.60
37,308.65
61.00
4,508.90
19.56
554
38.32
60.26
1,970.00
33,066.22
56.20
2,864.20
12.11
510
27.40
56.77
417.30
16,845.11
89.90
3,809.40
2.56
317
-52.01
61.54
516.35
16,369.65
87.60
2,124.50
20.92
168
#1 55.62
63.62

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
28.16 %
Net Income Growth
-41.66 %
Cash Flow Change
-12.20 %
ROE
-44.84 %
ROCE
-37.79 %
EBITDA Margin (Avg.)
-20.70 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Sept 2026
Revenue
268
206
411
361
363
478
417
398
388
501
588
569
581
609
655
609
638
693
782
790
812
879
965
1,003
1,087
1,197
1,376
Expenses
203
165
268
268
258
330
283
264
259
358
412
411
413
449
475
459
475
509
559
585
599
679
757
799
879
956
1,085
EBITDA
65
40
143
93
105
148
134
134
129
143
177
158
168
160
180
150
163
184
223
205
213
200
208
204
208
241
292
Operating Profit %
24 %
18 %
34 %
26 %
28 %
30 %
31 %
33 %
31 %
28 %
27 %
27 %
28 %
26 %
27 %
24 %
25 %
26 %
28 %
24 %
25 %
22 %
21 %
20 %
18 %
19 %
19 %
Depreciation
17
17
16
20
17
17
18
19
19
29
31
33
35
32
33
35
46
39
41
45
53
53
66
79
85
101
121
Interest
10
9
7
9
7
6
3
3
4
6
8
12
5
9
9
12
16
18
20
26
27
33
45
57
68
83
66
Profit Before Tax
38
14
120
65
81
125
113
112
107
107
138
113
127
119
139
102
100
127
162
135
134
114
97
69
55
57
106
Tax
10
5
29
17
22
33
29
28
24
28
31
31
29
32
37
26
29
32
42
42
28
29
25
17
22
19
31
Net Profit
28
9
90
48
59
92
84
84
83
79
106
82
99
87
101
77
72
95
121
93
106
85
72
52
33
37
75
EPS in ₹
3.72
1.49
11.21
6.55
7.72
11.48
10.34
10.14
10.08
8.74
12.14
9.49
11.65
10.10
11.50
8.98
8.18
10.82
2.68
2.22
2.54
1.96
1.67
1.33
1.06
1.04
1.79

Balance Sheet

Balance Sheet
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Total Assets
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
7,759
Fixed Assets
755
863
916
931
1,005
1,766
2,434
3,349
5,710
Capital Work in Progress
0
0
2
9
21
477
600
1,214
606
Investments
0
0
0
0
333
68
157
99
103
Other Assets
203
254
278
496
549
630
660
1,075
1,339
Total Equity & Liabilities
958
1,118
1,196
1,436
1,907
2,941
3,852
5,736
7,759
Current Liabilities
749
201
219
278
215
297
452
836
1,239
Non Current Liabilities
347
351
366
282
282
707
1,307
2,481
3,961
Total Equity
-138
566
611
876
1,411
1,938
2,093
2,419
2,559
Reserve & Surplus
-209
466
523
786
1,307
1,590
1,748
2,058
2,167
Share Capital
50
75
75
78
80
80
80
80
80

Cash Flow

Cash Flow
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash Flow
5
-11
5
3
-3
33
12
-27
36
-15
9
-1
Investing Activities
-71
-41
-100
-64
-110
-125
-354
-412
-416
-753
-1,116
-1,452
Operating Activities
64
95
82
106
134
202
356
324
432
521
582
511
Financing Activities
12
-66
24
-39
-27
-44
10
61
20
217
543
940

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Sept 2026
Promoter
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
34.11 %
34.11 %
34.11 %
34.11 %
32.50 %
32.66 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.61 %
8.61 %
0.00 %
14.25 %
0.00 %
16.73 %
17.84 %
15.85 %
15.68 %
15.45 %
15.54 %
15.03 %
14.33 %
14.57 %
14.44 %
15.01 %
DIIs
13.81 %
16.11 %
18.35 %
18.49 %
20.46 %
27.98 %
28.32 %
29.76 %
33.03 %
34.80 %
31.63 %
33.13 %
32.12 %
32.30 %
32.05 %
31.95 %
31.66 %
32.12 %
32.71 %
32.50 %
34.59 %
33.22 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.14 %
14.23 %
13.38 %
12.88 %
11.81 %
11.50 %
11.32 %
11.10 %
11.22 %
11.15 %
10.84 %
10.73 %
10.61 %
10.55 %
10.97 %
11.24 %
11.58 %
11.72 %
11.76 %
11.84 %
11.22 %
11.83 %
Others
34.21 %
30.82 %
29.42 %
29.79 %
28.88 %
21.68 %
12.92 %
11.69 %
16.91 %
0.96 %
18.70 %
0.59 %
0.61 %
2.48 %
2.48 %
2.54 %
7.11 %
7.03 %
7.09 %
6.98 %
7.25 %
7.28 %
No of Share Holders
0
267
86,389
74,355
73,664
70,795
67,735
60,980
65,449
66,957
71,014
69,092
69,063
77,617
95,468
1,01,895
1,08,955
1,04,872
1,01,599
93,333
95,710
95,609

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2024 389.93 502.38
13 Sept 2024 SPLIT Split
2:10
13 Sept 2024 420.62 547.18
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 520.35 570.15
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 606.05 649.15
12 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 May 2025 657.35 635.00
06 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Aug 2025 763.85 741.05
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 635.00 737.40
07 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2025 720.20 720.15
06 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2026 593.55 606.45
15 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2026 675.95 773.30
09 Jul 2026 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
09 Jul 2026 785.10 806.15
03 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
03 Aug 2026 800.45 804.70
27 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Aug 2026 761.60 756.10
04 Nov 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Nov 2026 666.15 730.50

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
Deviation Report - QIP2 days ago
Deviation Report - Preferential Allotment2 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report2 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency Report2 days ago
Announcement under Regulation 30 (LODR)-Scheme of Arrangement2 days ago
Announcement under Regulation 30 (LODR)-Change in Management2 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation2 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release2 days ago
Result For The Quarter Ended 30.09.20263 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On 04Th November 2026 Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.3 days ago
General Update6 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition8 days ago
Announcement under Regulation 30 (LODR)-Updates on Acquisition8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
General Announcement9 days ago
Board Meeting Intimation for To Consider And Approve The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 02Nd Quarter And Half-Year Ended September 30 2026.Oct 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 19, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2026
General Update On Query Received From BSEOct 08, 2026
General Update To Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 07, 2026
Announcement under Regulation 30 (LODR)-AcquisitionOct 06, 2026
Announcement under Regulation 30 (LODR)-AcquisitionOct 06, 2026
Announcement under Regulation 30 (LODR)-AcquisitionOct 06, 2026
Announcement under Regulation 30 (LODR)-AcquisitionOct 06, 2026
Closure of Trading WindowSep 26, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Sep 23, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 07, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 30, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 27, 2026
Clarification Regarding Article Appearing In Dealstreetasia.Com Dated 25Th August 2026 Titled Chryscapital- Backed KIMS In Talks To Acquire Stake In Renova Hospitals For $52 MillionAug 26, 2026
KIMS Has Entered Into An Operations And Management Agreement And Call Option Agreement With Aurevia Hospitals Private Limited (Formerly Known As Golden Lan Solution Private Limited) Hyderabad TelanganaAug 20, 2026
Announcement under Regulation 30 (LODR)-AllotmentAug 20, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 08, 2026
Intimation Of Receipt Of The In-Principle Approval From BSE Limited And The National Stock Exchange Of India LimitedAug 07, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2026
Letter To Shareholders Regarding Annual ReportAug 05, 2026
Business Responsibility and Sustainability Reporting (BRSR)Aug 05, 2026
Reg. 34 (1) Annual Report.Aug 05, 2026
24Th Annual General Meeting Of The Company Scheduled To Be Held On 27Th August 2026Aug 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 04, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 04, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 04, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 03, 2026
Statement Of DeviationAug 03, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 03, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Axis Services Opportunities Fund Direct-Growth
0.00%
-582292
-3.32%
-2.96%
Invesco India Pharma And Healthcare Fund Direct-Growth
0.00%
-275638
-4.72%
0.00%
Invesco India Consumption Fund Direct-Growth
0.00%
-239802
-3.03%
-2.43%
Groww Small Cap Fund Direct-Growth
0.00%
-113781
-0.88%
-1.13%
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-47040
-0.89%
-0.89%
Kotak Services Fund Direct-Growth
0.00%
-35797
-0.38%
-0.36%
WhiteOak Capital Aggressive Hybrid Fund Direct-Growth
0.00%
-23799
-0.29%
-0.33%
WhiteOak Capital Consumption Opportunities Fund Direct-Growth
0.00%
-23653
-1.24%
-1.28%
DSP Nifty Healthcare Index Fund Direct-Growth
0.00%
-5880
-1.76%
0.00%
WhiteOak Capital Equity Savings Fund Direct-Growth
0.00%
-4398
-0.22%
-0.12%
JioBlackRock Sector Rotation Fund Direct-Growth
0.00%
-3679
-0.17%
-0.17%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
-2078
-0.89%
-0.88%
UTI Nifty 500 Index Fund Direct-Growth
0.00%
-1411
-0.10%
-0.10%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth
0.00%
-1156
-0.45%
-0.46%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.00%
-779
-0.10%
-0.09%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.00%
-524
-0.32%
-0.30%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
-230
-0.10%
-0.10%
Kotak Small Cap Fund Direct-Growth
0.00%
0
0.00%
-3.30%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.89%
Bajaj Finserv Healthcare Fund Direct-Growth
0.00%
0
0.00%
-0.92%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.00%
0
0.00%
-1.25%
Bandhan Healthcare Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Mid Cap Fund Direct-Growth
0.00%
0
0.00%
-1.21%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.89%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
-0.10%

Technical Indicators

RSI(14)
Neutral
52.67
ATR(14)
Less Volatile
21.97
STOCH(9,6)
Overbought
82.11
STOCH RSI(14)
Overbought
87.99
MACD(12,26)
Bullish
8.17
ADX(14)
Strong Trend
26.26
UO
Bearish
50.02
ROC
Uptrend And Accelerating
7.25
WillR
Neutral
-25.94

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and...more
Listing Date
28 Jun, 2021(5 Years, 4 Months, 10 Days)
Chairperson NameBhaskara Rao Bollineni